Evaluation of serum amyloid A as a biomarker for sepsis diagnosis compared with C-reactive protein, procalcitonin, and presepsin

The application of SAA in the early diagnosis of sepsis holds substantial clinical promise, particularly when employed alongside established biomarkers such as PCT, CRP, and presepsin. This combinatory approach may enhance diagnostic accuracy.

Authors

Institutions

Publication Details

Journal
Laboratory Medicine
Published
2025-12-26
DOI
https://doi.org/10.1093/labmed/lmaf054
Primary Topic
Sepsis Diagnosis and Treatment
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Evaluation of serum amyloid A as a biomarker for sepsis diagnosis compared with C-reactive protein, procalcitonin, and presepsin

Myeong Hee Kim, Wooin Lee, Sang-Wook Kang, Min Young Lee
Laboratory Medicine
Sepsis Diagnosis and Treatment
article

Evaluation of serum amyloid A as a biomarker for sepsis diagnosis compared with C-reactive protein, procalcitonin, and presepsin

Myeong Hee Kim, Wooin Lee, Sang-Wook Kang, Min Young Lee
article en

Abstract

The application of SAA in the early diagnosis of sepsis holds substantial clinical promise, particularly when employed alongside established biomarkers such as PCT, CRP, and presepsin. This combinatory approach may enhance diagnostic accuracy.

Laboratory MedicineVol. 57(2)
Kyung Hee University Hospital at Gangdong (KR)
Openalex Percentile: Top 24%
Sepsis Diagnosis and Treatment
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.